{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T02:56:53Z","timestamp":1721444213199},"reference-count":30,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.3892\/ol.2014.2168","type":"journal-article","created":{"date-parts":[[2014,5,22]],"date-time":"2014-05-22T13:23:46Z","timestamp":1400765026000},"page":"841-844","source":"Crossref","is-referenced-by-count":4,"title":["JAK2 V617F detected in two B-cell chronic lymphocytic leukemia patients without coexisting Philadelphia chromosome-negative myeloproliferative neoplasms: A report of two cases"],"prefix":"10.3892","volume":"8","author":[{"given":"YI-NING","family":"YANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOU-WEN","family":"QIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHUN","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,5,22]]},"reference":[{"key":"key20180108104600_b1-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"key20180108104600_b2-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood-2005-05-1800","article-title":"JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia","volume":"106","author":"Jelinek","year":"2005","journal-title":"Blood"},{"key":"key20180108104600_b3-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1182\/blood-2005-05-1898","article-title":"The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia","volume":"106","author":"Levine","year":"2005","journal-title":"Blood"},{"key":"key20180108104600_b4-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000111532","article-title":"Evaluation of JAK2 in B and T cell neoplasms: identification of JAK2(V617F) mutation of undetermined significance (JMUS) in the bone marrow of three individuals","volume":"118","author":"Wang","year":"2007","journal-title":"Acta Haematol"},{"key":"key20180108104600_b5-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1756-8722-4-4","article-title":"Relevance of JAK2V617F positivity to hematological diseases - survey of samples from a clinical genetics laboratory","volume":"4","author":"Zhao","year":"2011","journal-title":"J Hematol Oncol"},{"key":"key20180108104600_b6-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000338831","article-title":"No evidence for JAK2(V617F) mutation in monoclonal B cells in 2 patients with polycythaemia vera and concurrent monoclonal B cell disorder","volume":"128","author":"Stijnis","year":"2012","journal-title":"Acta Haematol"},{"key":"key20180108104600_b7-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00277-011-1256-6","article-title":"Chronic lymphocytic leukemia developing in a patient with Janus kinase 2 V617F mutation positive myeloproliferative neoplasm","volume":"91","author":"Eskazan","year":"2012","journal-title":"Ann Hematol"},{"key":"key20180108104600_b8-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1016\/j.leukres.2009.06.027","article-title":"JAK2 mutation in a patient with CLL with coexistent myeloproliferative neoplasm (MPN)","volume":"33","author":"Kodali","year":"2009","journal-title":"Leuk Res"},{"key":"key20180108104600_b9-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.leukres.2008.09.002","article-title":"Zap-70 positive chronic lymphocytic leukemia co-existing with Jak 2 V671F positive essential thrombocythemia: a common defective stem cell?","volume":"33","author":"Tabaczewski","year":"2009","journal-title":"Leuk Res"},{"key":"key20180108104600_b10-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ajh.22171","article-title":"The coexistence of chronic lymphocytic leukemia and myeloproliferative neoplasms: a retrospective multicentric GIMEMA experience","volume":"86","author":"Laurenti","year":"2011","journal-title":"Am J Hematol"},{"key":"key20180108104600_b11-ol-08-02-0841","first-page":"2076","article-title":"JAK2 V617F positive essential thrombocythemia developing in a patient with CD5\u2212 chronic lymphocytic leukemia","volume":"125","author":"Wei","year":"2012","journal-title":"Chin Med J (Engl)"},{"key":"key20180108104600_b12-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ajh.23362","article-title":"Concomitant JAK2 V617F-positive polycythemia vera and B-cell chronic lymphocytic leukemia in three patients originating from two separate hematopoietic stem cells","volume":"88","author":"Swierczek","year":"2013","journal-title":"Am J Hematol"},{"key":"key20180108104600_b13-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000243721","article-title":"Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and in two relatives with lymphoproliferative disorders","volume":"122","author":"Musolino","year":"2009","journal-title":"Acta Haematol"},{"key":"key20180108104600_b14-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/ajh.20870","article-title":"Association of essential thrombocythemia and chronic lymphocytic leukemia: absence of the V617F JAK2 mutation in the lymphoid compartment","volume":"82","author":"Henry","year":"2007","journal-title":"Am J Hematol"},{"key":"key20180108104600_b15-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.0902-4441.2006.t01-1-EJH2940.x","article-title":"B-CLL developing in a patient with PV is not affected by V617F mutation of the Janus kinase 2","volume":"77","author":"Hussein","year":"2006","journal-title":"Eur J Haematol"},{"key":"key20180108104600_b16-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ajh.23491","article-title":"Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment","volume":"88","author":"Hallek","year":"2013","journal-title":"Am J Hematol"},{"key":"key20180108104600_b17-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ajh.20663","article-title":"JAK2V617F mutation can occur exclusively in the erythroid lineage and be absent in granulocytes and progenitor cells in classic myeloproliferative disorders","volume":"81","author":"Zehentner","year":"2006","journal-title":"Am J Hematol"},{"key":"key20180108104600_b18-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1182\/blood-2006-04-017392","article-title":"Involvement of various hematopoietic-cell lineages by the JAK2V617F mutation in polycythemia vera","volume":"108","author":"Ishii","year":"2006","journal-title":"Blood"},{"key":"key20180108104600_b19-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2141.2007.06497.x","article-title":"The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders","volume":"136","author":"Larsen","year":"2007","journal-title":"Br J Haematol"},{"key":"key20180108104600_b20-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood-2006-03-007146","article-title":"Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis","volume":"109","author":"Delhommeau","year":"2007","journal-title":"Blood"},{"key":"key20180108104600_b21-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3324\/haematol.10527","article-title":"B-, T-, and NK-cell lineage involvement in JAK2V617F-positive patients with idiopathic myelofibrosis","volume":"92","author":"Bogani","year":"2007","journal-title":"Haematologica"},{"key":"key20180108104600_b22-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2141.2006.06206.x","article-title":"The role of Janus kinases in haemopoiesis and haematological malignancy","volume":"134","author":"Khwaja","year":"2006","journal-title":"Br J Haematol"},{"key":"key20180108104600_b23-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1182\/blood-2005-03-1287","article-title":"On the molecular origins of the chronic myeloproliferative disorders: it all makes sense","volume":"105","author":"Kaushansky","year":"2005","journal-title":"Blood"},{"key":"key20180108104600_b24-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signaling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"key20180108104600_b25-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/sj.leu.2404026","article-title":"A transgenic mouse model for TEL-JAK2-induced B-cell lymphoma\/leukemia","volume":"20","author":"dos Santos","year":"2006","journal-title":"Leukemia"},{"key":"key20180108104600_b26-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/sj.leu.2404104","article-title":"A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma","volume":"20","author":"Ad\u00e9la\u00efde","year":"2006","journal-title":"Leukemia"},{"key":"key20180108104600_b27-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4049\/jimmunol.168.1.466","article-title":"Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T\/null-cell lymphoma","volume":"168","author":"Zhang","year":"2002","journal-title":"J Immunol"},{"key":"key20180108104600_b28-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1182\/blood-2004-09-3701","article-title":"Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line","volume":"105","author":"Melzner","year":"2005","journal-title":"Blood"},{"key":"key20180108104600_b29-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/sj.leu.2404292","article-title":"The JAK2V617F mutation is detectable at very low level in peripheral blood of healthy donors","volume":"20","author":"Sidon","year":"2006","journal-title":"Leukemia"},{"key":"key20180108104600_b30-ol-08-02-0841","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/blood-2006-03-009472","article-title":"JAK2(V617F): Prevalence in a large Chinese hospital population","volume":"109","author":"Xu","year":"2007","journal-title":"Blood"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2014.2168\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T13:50:14Z","timestamp":1515419414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2014.2168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,22]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,5,22]]},"published-print":{"date-parts":[[2014,8]]}},"alternative-id":["10.3892\/ol.2014.2168"],"URL":"https:\/\/doi.org\/10.3892\/ol.2014.2168","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,22]]}}}